Novellia Recognized for AI Innovation in Health Records in 2025 MedTech Breakthrough Awards Program

Prestigious awards program honors Novellia's AI-enabled platform for transforming fragmented health records into real-world research breakthroughs

NEW YORK, May 8, 2025 /PRNewswire/ -- Novellia, Inc., an AI-enabled personal health data company redefining how real-world evidence is generated, today announced it has been named the winner of the "Best Electronic Health Record Service" award in the 9^th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market.

Novellia's AI-enabled platform seamlessly unifies fragmented medical histories into dynamic, longitudinal patient profiles—enabling new levels of precision in research, care delivery, and evidence generation. The company's AI-enabled approach uses automation and machine learning to autonomously organize, clean, and de-duplicate messy health records across tens of thousands of healthcare institutions and practices across the country—making it possible to detect care gaps, identify real-world treatment patterns, and power precision research at scale.

"At a time when fragmented health data continues to limit medical progress, we are honored to be recognized for building a more unified, precise, and patient-powered foundation for research," said Shashi Shankar, co-founder and CEO of Novellia. "Biopharma companies don't just need more data—they need better data, cleaned and neatly organized from the start and continuously updated. Our AI-enabled platform delivers exactly that: high-fidelity, longitudinal patient datasets that help surface insights faster, unlock new precision across the entire biopharma value chain, and bring more precise treatments to the people who need them."

Unlike legacy health data platforms that provide static, institution-centric snapshots, often missing entire chapters of a patient's journey, Novellia unifies complete, longitudinal health records across systems and time—directly from the patient. The results are dynamic, next generation real world datasets that reflect the full real-world experience. With independent access to over 92% of U.S. health records, including major systems like EPIC and McKesson, Novellia's data has already powered landmark studies in oncology and rare disease—surfacing critical insights legacy datasets couldn't detect.

"Fragmented data remains one of healthcare's greatest barriers to innovation, and Novellia is tackling that challenge head-on with a scalable, AI-enabled model," said Steve Johansson, managing director, MedTech Breakthrough. "Many legacy data solutions are unable to detect care gaps, and the current practice of collecting and sharing volumes of scattered health data really limits therapeutic research potential. By unifying fragmented patient records in ways never before possible, bridging data gaps, and maintaining privacy and security, Novellia is paving the way for a smarter, more connected healthcare ecosystem that will ultimately lead to improved therapeutic development and overall patient care."

With Novellia, it's a win-win. Patients can more easily manage their care while contributing anonymized data to research that drives better outcomes, and researchers gain faster access to cleaner data linked to outcomes and patient-reported insights. Using Novellia's AI-enabled technology, biopharma companies, health systems, and research institutions can quickly collaborate through the platform to surface insights, match patients to research, and accelerate development of more personalized, evidence-based treatments.

About Novellia
Novellia is the AI-enabled personal health data company redefining how real-world evidence is generated. By unifying fragmented patient records into comprehensive, longitudinal datasets, Novellia gives researchers at leading biopharma companies unprecedented visibility into the full patient journey. Patients gain control over their health information through Novellia's advanced health record portal, with the unique opportunity to contribute their anonymized data to advance scientific research and discovery.

Through proprietary AI and patient-permissioned data access, Novellia helps biopharma and healthcare systems uncover insights faster and develop more targeted, evidence-based solutions. Setting a new benchmark for real-world data quality, Novellia applies the highest standards of scientific rigor to deliver scalable, next-generation datasets that pave the way for improved therapeutic development and overall patient care. To learn more visit novellia.com.

About MedTech Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.

Tech Breakthrough LLC does not endorse any vendor, product or service depicted in our recognition programs, and does not advise technology users to select only those vendors with award designations. Tech Breakthrough LLC recognition consists of the opinions of the Tech Breakthrough LLC organization and should not be construed as statements of fact. Tech Breakthrough LLC disclaims all warranties, expressed or implied, with respect to this recognition program, including any warranties of merchantability or fitness for a particular purpose.

Media Contact
Novella Communications
[email protected]

SOURCE Novellia